Ruicci, K. M., Deng, Y., Xiao, T., Eskander, A., Goldstein, D. P., Mete, O., Mesci, A., Lukovic, J., Krzyzanowska, M. K., Barron, C. C., Ma, L. X. (2025). Real-world treatment outcomes and clinicopathologic determinants of response for patients with advanced thyroid cancer treated with first-line lenvatinib.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e18132